OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database
M. Martin, Hoan-My Nguyen, C. Beuvon, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5030-5030
Open Access | Times Cited: 9
M. Martin, Hoan-My Nguyen, C. Beuvon, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5030-5030
Open Access | Times Cited: 9
Showing 9 citing articles:
PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review
Donald C. Moore, Joseph B. Elmes, Justin Arnall, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111606-111606
Closed Access | Times Cited: 14
Donald C. Moore, Joseph B. Elmes, Justin Arnall, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111606-111606
Closed Access | Times Cited: 14
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 7
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 7
Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Antithymocyte Globulin for Aplastic Anemia Secondary to Pembrolizumab: A Case Report and Review of Literature
Cynthia Yeung, Nicole Relke, David Good, et al.
Immunotherapy (2023) Vol. 15, Iss. 5, pp. 323-333
Closed Access | Times Cited: 4
Cynthia Yeung, Nicole Relke, David Good, et al.
Immunotherapy (2023) Vol. 15, Iss. 5, pp. 323-333
Closed Access | Times Cited: 4
Immune checkpoint inhibitor-related acquired amegakaryocytosis thrombocytopenia: a case report and literature review
V. Rivet, V. Sibaud, J. Dion, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
V. Rivet, V. Sibaud, J. Dion, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Case Report: Life-threatening pancytopenia with tislelizumab followed by cerebral infarction in a patient with lung adenocarcinoma
Hangyu Gu, Jingwen Zhao, Yin-Shuang Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Hangyu Gu, Jingwen Zhao, Yin-Shuang Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis in a Patient with Chronic Lymphocytic Leukemia
Syed Ali, Bryone J. Kuss, Christos S. Karapetis, et al.
Immunotherapy (2023) Vol. 15, Iss. 18, pp. 1531-1537
Closed Access | Times Cited: 2
Syed Ali, Bryone J. Kuss, Christos S. Karapetis, et al.
Immunotherapy (2023) Vol. 15, Iss. 18, pp. 1531-1537
Closed Access | Times Cited: 2
Редкие иммуноопосредованные нежелательные явления: клиническая характеристика, подходы к диагностике и лечению
Lyudmila Zhukova, О. С. Пасечнюк, Natalya I. Polshina, et al.
Malignant tumours (2024) Vol. 14, Iss. 3s1, pp. 53-62
Open Access
Lyudmila Zhukova, О. С. Пасечнюк, Natalya I. Polshina, et al.
Malignant tumours (2024) Vol. 14, Iss. 3s1, pp. 53-62
Open Access
Srilatha Dasari, William Tse, Jiasheng Wang
British Journal of Haematology (2023) Vol. 202, Iss. 6, pp. 1205-1208
Closed Access | Times Cited: 1
